Pharma News

In a disappointing turn of events, the proposed settlement of $13.5 million in the long-standing class-action lawsuit regarding insulin pricing has been withdrawn, highlighting the challenges of resolving the issue.

With strategic partnerships with pharmaceutical giants like Novartis and Sanofi, CotaHealthcare is leveraging real-world data (RWD) and AI to revolutionize oncology drug development, including the treatment of multiple myeloma.

This article delves into the factors that contributed to its success and highlights the potential implications for the future of biotech in China.

This article highlights Huadong Medicine's achievements, particularly in the pharmaceutical industry, and explores its innovative advancements in the fields of endocrinology, immunology, and oncology.

Let's delve into the details and explore the factors contributing to Hengrui Pharmaceutical's groundbreaking success.

In a significant development, pharmaceutical giant AbbVie has announced its collaboration with French-listed company Medincell to jointly develop and commercialize a range of therapeutic products across multiple treatment areas and indications.

Regeneron, a pharmaceutical company with a rich history spanning 35 years, is venturing into the realm of risk investment.

This article sheds light on the diverse applications and benefits of cetostearyl alcohol in different industries. Explore how this compound contributes to product formulations and enhances their effectiveness.

Singapore's Deputy Prime Minister and Minister for Economic Policies, Heng Swee Keat, recently visited China, where he placed special emphasis on an AI pharmaceutical company, as reported by Yaozh News.

Roche's PI3K inhibitor, Inavolisib, has been granted priority review status by the National Medical Products Administration (NMPA).

Innovent Biologics, a leading pharmaceutical company, has recently announced the appointment of Dr. Nageatte Ibrahim as the Chief Medical Officer of Oncology.

This article presents a comprehensive overview of the latest advancements in PROTAC technology and its potential in revolutionizing the field of oncology.

Novartis, one of the leading global pharmaceutical companies, has recently announced a groundbreaking strategic partnership with Arvinas to advance the development of an oral protein degrader for the treatment of prostate cancer.

The pursuit of eternal youth has led to unprecedented growth in the medical aesthetics industry, particularly in the realm of botulinum toxin, commonly known as Botox.

In a recent development, Genentech, a subsidiary of Roche, has announced its decision to implement a workforce reduction plan, impacting over 400 employees.

In a shocking turn of events, the price of a well-known medication for hemorrhoids, known as "Taining" or "Taining," has surged nearly tenfold after being discontinued for six months.

In a groundbreaking collaboration, pharmaceutical giant Merck has joined forces with AI biotech company Caris Discovery to develop transformative ADC (Antibody-Drug Conjugate) therapies.

Novartis, one of the leading pharmaceutical companies globally, has announced plans to implement a significant workforce reduction, resulting in the termination of approximately 700 positions.

Vertex Pharmaceuticals, a prominent US-based biotech company, has recently made a significant move into the field of immunotherapy through a multi-billion dollar acquisition.

In this article, we will delve into the misconceptions surrounding DRG and shed light on its actual implications for hospitals. Contrary to popular belief, DRG should not be solely blamed for reduced medical income and hospital deficits.